 UTRECHT, The Netherlands and PHILADELPHIA, May 18, 2021 GLOBE NEWSWIRE -- LAVA Therapeutics N.V. Nasdaq: LVTX, a biotechnology company focused on applying its expertise in bispecific gamma-delta T cell engagers to transform cancer therapy, today announced that Stephen Hurly, chief executive officer, will present at the 2021 UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021 at 1:00 p.m. ET. 